Vor Bio Deal History & Licensing Activity
Vor Bio is a life sciences. Over the past three years, Vor Bio has been involved in 2 licensing and acquisition transactions, with a primary focus on Other (3 deals).
Deals (12mo)
3
Active Trials
0
Top Modality
Other
Focus Area
Immunology
Vor Bio Recent Deal Activity
Licensing, acquisition, and partnership transactions involving Vor Bio in the past 12 months.
| Asset | Partner | Modality | Phase | Type | Date |
|---|---|---|---|---|---|
| late-stage autoimmune drug | RemeGen | Other | Phase 2 | license | Jun 2025 |
Vor Bio Pipeline Focus
Therapeutic areas and modalities where Vor Bio is most active based on deal history and clinical trial data.
Therapeutic Areas
Modalities
See How Your Asset Matches Vor Bio's Portfolio
Use our deal calculator to benchmark upfront payments, milestones, and royalties for Immunology assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
Immunology Deal Benchmarks
Market sizing, deal terms, and competitive landscape for immunology
Other Benchmarks
Upfront, milestone, and royalty benchmarks for other deals
Deal Pulse
Track the latest biopharma licensing and acquisition deals across all therapeutic areas
All Company Profiles
Browse 850+ biotech and pharma company profiles with deal history and pipeline data
2026 Deal Benchmarks Report
Industry-wide analysis of deal terms, trends, and market dynamics
About Vor Bio Licensing & Deal Activity
Vor Bio is a life sciences company that has been actively engaged in licensing transactions across the biopharma landscape. With 2 deals over the past three years, Vor Bio ranks among the actively acquisitive companies tracked by Ambrosia Ventures.
Key therapeutic areas of focus for Vor Bio include Immunology (3 deals and trials). In terms of modality, Vor Bio has shown particular interest in other.
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Vor Bio and 850+ other biopharma companies. Use our deal calculator to benchmark your asset against Vor Bio's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.